 | Up a level |
Heesen, C; Mokry, C; Salmen, A; Hegen, H; Mäurer, M; Warnke, C; Gehring, K; Berthele, A; Meier, U (2022). German guideline for diagnosis and treatment of multiple sclerosis - a survey focusing neurologists in daily practise. Multiple Sclerosis and Related Disorders, 63, p. 103828. Elsevier 10.1016/j.msard.2022.103828
Mokry, C; Warnke, C; Gehring, K; Hegen, H; Salmen, A; Kraemer, M; Kleiter, I; Fasshauer, E; Scheiderbauer, J; Lühmann, D; Köpke, S; Berthele, A; Heesen, C (2022). Implementation study of the 2021 German guideline for diagnosis and treatment of multiple sclerosis. Multiple Sclerosis and Related Disorders, 57, p. 103434. Elsevier 10.1016/j.msard.2021.103434
Klotz, L; Berthele, A; Brück, W; Chan, Andrew; Flachenecker, P; Gold, R; Haghikia, A; Hellwig, K; Hemmer, B; Hohlfeld, R; Korn, T; Kümpfel, T; Lang, M; Limmroth, V; Linker, R A; Meier, U; Meuth, S G; Paul, F; Salmen, Anke; Stangel, M; ... (2016). [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt, 87(6), pp. 645-659. Springer 10.1007/s00115-016-0077-1
